YatırımMasasıYatırım Masası home
Jeffrey G. Lamothe, Aptevo Therapeutics option exercise
CEO, SEC Form 4, filed on August 11, 2026
+961 sharesnet change in holding. Not an open-market purchase or sale
- Transaction date
- August 6, 2026
- Shares held after
- 961Direct ownership
- Change in holding
- Could not be calculatedFrom the transactions in the filing
- Filing rows
- 1None is a purchase or sale
Price context
APVO daily close, Apr 8 to October 27, 2026$5.61$1.29
Daily close
Grants, options, tax
- Transaction price
- Not reportedNot an open-market trade
- Close on trade date
- $4.07August 6, 2026
- Latest close
- $1.29October 27, 2026
- Since the trade
- −68.31%vs the close on trade date
Transactions in the filing
DateTransactionSecuritySharesPriceAmountAfter
Option exercise
Common stockDirect
961
961
Recent filings at Aptevo Therapeutics
Full historyPersonTransactionAmount or sharesDate